Vikram Janardhan started Insera Therapeutics LLC six months ago in Sacramento to develop Shelter and other stroke-treatment technologies. The company is looking for $1.1 million in seed funding. It would use the money to develop five sizes of the prototype, which will fit into blood vessels from 2.5 millimeters to 5 millimeters wide.

2019-02-03

About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal, About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal, Evacuation, Aspiration, and Retrieval. The CLEAR TM Aspiration System is currently not cleared to market in the United States. Insera Therapeutics was a finalist at the 2018 Sacramento Innovation Awards. This video highlights the CLEAR Aspiration System. Assignee: Insera Therapeutics, Inc. Inventors: Vallabh Janardhan, Vikram Janardhan Circumferentially offset variable porosity devices SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever.

Employment. Source: Vallabh The grantee listed for this patent is Insera Therapeutics, Inc.. Invention is credited to Vallabh Janardhan, Vikram Janardhan. United States Patent, D896,847. WHO ARE WE. Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various Decibel Therapeutics, Inc. Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of. Teste do cateter em simulador de coáguloInsera Therapeutics.

Interested in knowing more about our innovative products and services? Contact us with your questions or comments. We want to hear from you!You can send us an email using the form on this page, or simply email us at info@inseratherapeutics.com.

Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last month, the first two stroke patients were treated using the same platform. Assignee: Insera Therapeutics, Inc. Inventors: Vallabh Janardhan, Vikram Janardhan.

Find company research, competitor information, contact details & financial data for Insera Therapeutics LLC of Sacramento, CA. Get the latest business insights from Dun & Bradstreet.

Insera Therapeutics takes vacuum aspiration therapy to a new level with a disruptive digital design and cyclical aspiration for mechanical thrombectomy. Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital Find company research, competitor information, contact details & financial data for Insera Therapeutics LLC of Sacramento, CA. Get the latest business insights from Dun & Bradstreet. SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever. Insera Therapeutics notes their unique aspiration technology offers the ability to vary the vacuum suction pressures and intervals within the safe vacuum suction range up to -98.2 kPa (-29 inHg). reports latest medical device, biotech, diagnostic executives on the move and more About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal Vikram Janardhan started Insera Therapeutics LLC six months ago in Sacramento to develop Shelter and other stroke-treatment technologies. The company is looking for $1.1 million in seed funding.

Coágulos no cérebro. Quando uma pessoa sofre um acidente vascular cerebral - um derrame - o tempo é uma questão crítica - mais de um milhão de células cerebrais morrem a cada minuto, privadas da sua fonte de alimento devido ao dano no vaso sanguíneo que as abastecia. 24 May 2019 Insera Therapeutics Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR 15 Oct 2019 CLEAR system Insera Therapeutics has announced that the first two ischaemic stroke patients have been treated with its cyclic aspiration 13 Mar 2019 Insera Therapeutics' CEO Vikram Janardhan gives a glimpse into future stroke devices, the innovation behind the CLEAR Aspiration System, 9 Apr 2019 Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the 2 Dec 2019 December 2, 2019—Insera Therapeutics, Inc. announced that Clear, the company's cyclical aspiration system, was used for the first time to 12 Nov 2020 As co-founders of Insera Therapeutics Inc, Vallabh, 46, and Vikram, 49, have invented, among other things, a flagship device called Clear, 11 Jan 2019 Minimally invasive brain surgery using Insera Therapeutics' cyclical vacuum aspiration technology. The next frontier for treating 17 Mar 2021 Insera Therapeutics, Inc. : Dallas, Texas, US. 2017 to present | Co-founder & Chief Medical Officer (CMO). Employment. Source: Vallabh The grantee listed for this patent is Insera Therapeutics, Inc..
Ratt rekrytering

Infant Bacterial Therapeutics AB · Iron Mountain Nordic · IDkollen i Sverige AB Institutionen för tillämpad IT · IAU Institutet för arbetsliv och utveckling · Insera Genentech.

Insera Therapeutics, Inc. United States of America : Total IP: 65: Total IP Rank # 18,624 IP Activity Score: 2.2/5.0 33 IP To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting. Insera Therapeutics is a Sacramento, CA based medical devices company. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and Insera Therapeutics' CEO Vikram Janardhan gives a glimpse into future stroke devices, the innovation behind the CLEAR Aspiration System, and the Get reviews, hours, directions, coupons and more for Insera Therapeutics.
Hur ser man hur mycket skuld man har hos kronofogden

parfym svensk
vänsterpartiets nya ledare
smak certifiering
svt uutiset facebook
rene descartes i think therefore i am
molndals kommun kontakt

Insera Therapeutics, Inc. 2018 - Present 3 years. Dallas/Fort Worth Area Stroke & Interventional Neurologist, Medical Staff Medical

Heated mechanical detachment for delivery of therapeutic devices: September, 2009: Jones et al. 20090209855: MEDICAL DEVICES FOR TREATING A TARGET SITE AND ASSOCIATED METHOD: August, 2009: Drilling et al. 20090198269: Device for the Removal of Thrombi From Blood Vessels: August, 2009: Hannes et al. 7572290 About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal Find company research, competitor information, contact details & financial data for Insera Therapeutics LLC of Sacramento, CA. Get the latest business insights from Dun & Bradstreet.

17 Mar 2021 Insera Therapeutics, Inc. : Dallas, Texas, US. 2017 to present | Co-founder & Chief Medical Officer (CMO). Employment. Source: Vallabh

3,717 days. Methods, apparatus and products for filtering. Patent No. 1b; Insera Therapeutics, Inc.), which is part of the InseraTM System and used in conjunction with the CLEARTM Aspiration System (the SHELTER® Retriever, 15 Oct 2020 Insera Therapeutics*; Patents (Planned, Pending or Issued): Patents related to balloon-guided technology*; Stock/Stock Options: Marblehead medical technologies.

353 gillar detta.